- 3-aryl azabicyclo derivative as well as preparation and application thereof in nematode killing
-
The invention relates to preparation of a 3-aryl azabicyclo derivative and application of the derivative in nematode killing. Specifically, the invention discloses application of a compound with a structure as shown in a formula (I) or a composition, an optical isomer, a cis-trans-isomer and an agricultural pharmacologically acceptable salt of the compound in the field of nematode killing.
- -
-
Paragraph 0104; 0106-0107; 0118-0121
(2021/08/06)
-
- Compound and application thereof
-
The invention provides a novel compound. The novel compound has certain inhibitory activity for indoleamine 2,3-dioxygenase (IDO) which is oxido-reductase, and accordingly the novel compound can be used for treating diseases related to the indoleamine 2,3-dioxygenase and can be applied to cancer and immunity related diseases.
- -
-
-
- ANALOGUES OF 4H-PYRAZOLO[1,5-a] BENZIMIDAZOLE COMPOUND AS PARP INHIBITORS
-
Disclosed is a series of analogues of 4H-pyrazolo[1,5-α]benzimidazole compound as PARP inhibitors. In particular, disclosed in the invention is a compound as shown by formula (I) or a pharmaceutically acceptable salt thereof as a PARP inhibitor.
- -
-
Paragraph 0392
(2017/02/28)
-
- NITROGENOUS HETEROCYCLIC DERIVATIVE HAVING 2,6-DISUBSTITUTED STYRYL
-
The invention provides a novel nitrogen-containing heterocyclic derivative having 2,6-disubstituted styryl and a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the nitrogen-containing heterocyclic derivative and a pharmaceutically acceptable salt thereof, in particular, a pharmaceutical composition effective as a sodium channel inhibitor, having an excellent analgesic action especially on neuropathic pain with minimized side effects.
- -
-
Page/Page column 16
(2010/02/14)
-
- GLYCINE TRANSPORTER-1 INHIBIRORS
-
The invention provides a compound of formula (I) or a salt or solvate thereof: wherein R1, and R3 and R10, X and Ar are as defined in the specification, and uses of such compounds. The compounds inhibit GlyT1 transporters
- -
-
Page/Page column 35-36
(2010/02/12)
-